The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractThe hemostatic system comprises platelet aggregation, coagulation and fibrinolysis and is a host defense mechanism that protects the integrity of the vascular system after tissue injury. During bacterial infections, the coagulation system cooperates with the inflammatory system to eliminate the invading pathogens. However, pathogenic bacteria have frequently evolved mechanisms to exploit the hemostatic system components for their own benefit. Streptococcus pyogenes, also known as Group A Streptococcus, provides a remarkable example of the extraordinary capacity of pathogens to exploit the host hemostatic system to support microbial survival and dissemination. The coagulation cascade comprises the contact system (also known as the intrinsic pathway) and the tissue factor pathway (also known as the extrinsic pathway), both leading to fibrin formation. During the early phase of S. pyogenes infection, the activation of the contact system eventually leads to bacterial entrapment within a fibrin clot, where S. pyogenes is immobilized and killed. However, entrapped S. pyogenes can circumvent the antimicrobial effect of the clot by sequestering host plasminogen on the bacterial cell surface that, after conversion into its active proteolytic form, plasmin, degrades the fibrin network and facilitates the liberation of S. pyogenes from the clot. Furthermore, the surface-localized fibrinolytic activity also cleaves a variety of extracellular matrix proteins, thereby enabling S. pyogenes to migrate across barriers and disseminate within the host. This review summarizes the knowledge gained during the last two decades on the role of coagulation/fibrinolysis in host defense against S. pyogenes as well as the strategies developed by this pathogen to evade and exploit these host mechanisms for its own benefit.
CitationThe role of coagulation/fibrinolysis during Streptococcus pyogenes infection. 2014, 4:128 Front Cell Infect Microbiol
AffiliationHelmholtz Centre for infection research, Inhoffenstr. 7, D38124 Braunschweig, Germany.
The following license files are associated with this item:
- Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots.
- Authors: Frick IM, Shannon O, Neumann A, Karlsson C, Wikström M, Björck L
- Issue date: 2018 Aug 31
- Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection.
- Authors: Deicke C, Chakrakodi B, Pils MC, Dickneite G, Johansson L, Medina E, Loof TG
- Issue date: 2016 Nov
- Modulation of the coagulation system during severe streptococcal disease.
- Authors: Shannon O, Herwald H, Oehmcke S
- Issue date: 2013
- Saliva-Induced Clotting Captures Streptococci: Novel Roles for Coagulation and Fibrinolysis in Host Defense and Immune Evasion.
- Authors: Wollein Waldetoft K, Mohanty T, Karlsson C, Mörgelin M, Frick IM, Malmström J, Björck L
- Issue date: 2016 Oct
- Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma.
- Authors: Herwald H, Mörgelin M, Dahlbäck B, Björck L
- Issue date: 2003 Feb